The Reliance Select cDNA Synthesis Kit is the newest reverse transcription product from Bio-Rad. This high-performance kit features Reliance Reverse Transcriptase, a novel chimeric enzyme that delivers superior results across a broad dynamic range, even with challenging samples. Engineered to overcome the processivity issues experienced with most reverse transcription kits, the Reliance Select cDNA Synthesis Kit delivers more accurate reverse transcription quantitative PCR (RT-qPCR) results, even from samples containing PCR inhibitors or degraded RNA.
Lower Cq Values, Even in the Presence of Inhibitors
The Reliance Select cDNA Synthesis kit delivers unrivaled performance with common PCR inhibitors, such as formalin and heparin. This kit provides more consistent results and earlier average Cq values than other commercial kits.
Greater Reverse Transcription Efficiency with Degraded Samples
The Reliance Select cDNA Synthesis Kit yields highly consistent results, regardless of whether RNA is intact or degraded (using heat treatment). Using housekeeping genes, we demonstrate a lower ΔCq value between reverse transcription kits with intact and degraded samples.
Unbiased Reverse Transcription and Superior Sensitivity
The Reliance Select cDNA Synthesis Kit transcribes low abundance targets, even in the presence of high RNA backgrounds, enabling greater sensitivity and more biologically relevant results.
Visit bio-rad.com/RelianceSelect for more information about the Reliance Select cDNA Synthesis Kit.